AVE 0.00% 0.3¢ avecho biotechnology limited

ConclusionAt present, there is limited evidence to support the...

  1. 2,650 Posts.
    lightbulb Created with Sketch. 777
    ConclusionAt present, there is limited evidence to support the clinical use of cannabinoid therapies for the treatment of any sleep disorder given the dearth of published research and the moderate-to-high risk of bias identified within the majority of clinical and preclinical studies completed to-date. Nonetheless, there are promising signs in a number of therapeutic applications that warrant additional study and there is a clear need for intensification of high-quality research into the safety and
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.